Lessee, Operating Lease, Liability, Undiscounted Excess Amount of VBI Vaccines Inc/BC from 30 Sep 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
VBI Vaccines Inc/BC quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD history and change rate from 30 Sep 2019 to 31 Mar 2024.
  • VBI Vaccines Inc/BC Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Mar 2024 was $276,000, a 54% decline year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

VBI Vaccines Inc/BC Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $276,000 -$318,000 -54% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $348,000 -$376,000 -52% 31 Dec 2023 10-K 16 Apr 2024 2023 FY
Q3 2023 $404,000 -$414,000 -51% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 $497,000 -$311,000 -38% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $594,000 -$395,000 -40% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $724,000 -$113,000 -14% 31 Dec 2022 10-K 13 Mar 2023 2022 FY
Q3 2022 $818,000 +$815,000 +27167% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $808,000 +$742,000 +1124% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $989,000 +$886,000 +860% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $837,000 +$694,000 +485% 31 Dec 2021 10-K 07 Mar 2022 2021 FY
Q3 2021 $3,000 -$176,000 -98% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $66,000 -$166,000 -72% 30 Jun 2021 10-Q 02 Aug 2021 2021 Q2
Q1 2021 $103,000 -$29,000 -22% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $143,000 -$36,000 -20% 31 Dec 2020 10-K 02 Mar 2021 2020 FY
Q3 2020 $179,000 -$42,000 -19% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 $232,000 30 Jun 2020 10-Q 31 Jul 2020 2020 Q2
Q1 2020 $132,000 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $179,000 31 Dec 2019 10-K 05 Mar 2020 2019 FY
Q3 2019 $221,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.